NCT06779890 2025-10-01
TIVolBrain
Aristotle University Of Thessaloniki
Phase 4 Recruiting
Clinical Trials
11 trialsNCT06710249 2025-01-27
AFBTEdema
Skane University Hospital
Phase 2 Recruiting
NCT03323580 2023-03-24
Effects of Intraoperative GDFT on the Postoperative Brain Edema
Beijing Tiantan Hospital
Phase NA Completed
NCT02460874 2022-09-21
Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593)
University of Alabama at Birmingham
Phase 1/2 Terminated
NCT04116138 2021-04-28
AFGBM1
Skane University Hospital
Phase 1/2 Completed
NCT04490954 2020-07-29
ABST
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Unknown
NCT00243022 2019-04-30
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT00088166 2014-08-13
XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
Celtic Pharma Development Services
Phase 3 Completed
NCT01369121 2013-07-30
Tolerability Study of Xerecept® in Pediatric Patients
Celtic Pharma Development Services
Phase 1/2 Terminated
NCT00226655 2012-08-31
An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
Celtic Pharma Development Services
Phase 3 Completed
NCT00226668 2008-01-03
XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Celtic Pharma Development Services
Phase 3 Withdrawn